Renergen Limited (JSE: REN)
South Africa
· Delayed Price · Currency is ZAR | Market Cap | 1.54B |
| Revenue (ttm) | 28.95M |
| Net Income (ttm) | -110.27M |
| Shares Out | 147.67M |
| EPS (ttm) | -0.75 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 57,286 |
| Open | 1,030.00 |
| Previous Close | 1,020.00 |
| Day's Range | 1,000.00 - 1,055.00 |
| 52-Week Range | 812.00 - 1,908.00 |
| Beta | 0.87 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 27, 2024 |
About Renergen
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. The company explores for, develops, and sells compressed natural gas, as well as liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which offers transportation of vaccines at low temperature without any electrical power. The company was founded in 2005 and is based in Sandton, South Africa. [Read more]
Financial Performance
In 2023, Renergen's revenue was 28.95 million, an increase of 128.20% compared to the previous year's 12.69 million. Losses were -110.27 million, 312.6% more than in 2022.
Financial StatementsNews
Big blow to Renergen
Renergen’s Tetra4 project cannot proceed with its expansion or undertake any activities associated with it following an appeal from environmental groups that was upheld.
Investors see opportunity after decade-long helium shortage. What you need to know.
A commodity by dictionary definition is something useful or valued, but here's one irreplaceable raw material that is hard to transport, has many more uses than you might think, and is often overlooke...